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ChemotherapyThe trypanosome alternative oxidase (TAO) functions in the African trypanosomes as a cytochrome-
independent terminal oxidase, which is essential for their survival in the mammalian host and as it does not
exist in the mammalian host is considered to be a promising drug target for the treatment of trypanosomiasis.
In the present study, recombinant TAO (rTAO) overexpressed in a haem-deﬁcient Escherichia coli strain
has been solubilized from E. coli membranes and puriﬁed to homogeneity in a stable and highly active form.
Analysis of bound iron detected by inductively coupled plasma-mass spectrometer (ICP-MS) reveals a
stoichiometry of two bound iron atoms permonomer of rTAO. Conﬁrmation that the rTAOwas indeed a diiron
protein was obtained by EPR analysis which revealed a signal, in the reduced forms of rTAO, with a g-value of
15. The kinetics of ubiquiol-1 oxidation by puriﬁed rTAO showed typical Michaelis–Menten kinetics (Km of
338 μM and Vmax of 601 μmol/min/mg), whereas ubiquinol-2 oxidation showed unusual substrate inhibition.
The speciﬁc inhibitor, ascofuranone, inhibited the enzyme in a mixed-type inhibition manner with respect
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Trypanosoma brucei is a parasite that causes African sleeping
sickness in humans and Nagana in livestock and is transmitted by the
tsetse ﬂy. There is an urgent need for further development of chemo-
therapy against African trypanosomiasis since current chemothera-
peutic drugs are not entirely satisfactory [1].
Trypanosomal parasites are equipped with a unique energy
metabolism, they live as the bloodstream form in the mammalian
host and as the procyclic form in the vector. The procyclic form of
T. brucei fulﬁlls its ATP requirement from a cyanide-sensitive andcytochrome-dependent respiratory chain comparable to that observed
in the host mitochondria, whereas in the bloodstream form, trypano-
somes use the glycolytic pathway, which is localized in a unique
organelle the glycosome, as their major source of ATP [2–5]. Once the
parasites invade the mammalian host in the bloodstream form, both
its cytochrome-dependent respiratory chain and ATP synthesis by
oxidative phosphorylation disappear [2,5]. Instead a cyanide-resistant
and cytochrome-independent trypanosomal alternative oxidase
(TAO) functions as the sole terminal oxidase to re-oxidize NADH
accumulated during glycolysis [5].
TAO is generally considered to be a good target for the anti-
trypanosomal drugs because this oxidase is essential for their survival,
since it reoxidises cytosolic NADH, and mammalian hosts do not
possess this protein [5,6]. Indeed,we found that ascofuranone, isolated
from the pathogenic fungus Ascochyta visiae, speciﬁcally inhibits
the quinol oxidase activity of TAO and rapidly kills the parasites [7].
In addition, we have conﬁrmed the chemotherapeutic efﬁcacy of
ascofuranone in vivo [8,9].
The alternative oxidase (AOX) is a non-protonmotive ubiquinol
oxido-reductase catalyzing the 4-electron reduction of dioxygen to
water [5,10–12]. Genes encoding AOX have been found in higher
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nematodes [13–16]. Moreover, recent bioinformatic searches have
broadened the taxonomic distribution of AOX to somemembers of the
animal kingdom [17]. The primary role of AOX in non-thermogenic
plants is to regulate cellular redox balance and to protect against
reactive oxygen species particularly when the cytochrome pathway is
inhibited [18–20]. In addition to this role, many other physiological
roles have been described for AOXs in other organisms and these have
been discussed in detail elsewhere [13,21]. The ubiquitous occurrence
of AOX may suggest that the metabolic ﬂexibility that the alternative
pathway confers upon an organism allows it to respond to a wide
range of developmental and environmental conditions [22].
Despite universal conservation of the gene and diversiﬁed
physiology, the molecular features of AOX have not yet been well
characterized. Although no high-resolution AOX structure has been
determined to date, current structural models predict that it is an
integral interfacial membrane protein that interacts with a single
leaﬂet of the lipid bilayer, and contains a non-haem diiron carboxylate
active site [23,24]. This model is supported by extensive site-directed
mutagenesis studies [18,25–29] and furthermore both EPR and FTIR
spectroscopies have conﬁrmed the presence of a binuclear iron center
in both the plant and trypanosomal enzymes [30–32].
Further detailed structural and biochemical analyses of AOXs,
however, requires further development of puriﬁcation protocols to
produce sufﬁciently puriﬁed and highly active protein to enable
crystallization trials and kinetic analyses to proceed. In this paper, we
report on the further reﬁnement of our previous protocol through
over-expressing rTAO in an E. coli ΔhemA mutant (FN102) strain,
which lacks quinol oxidase activity of cytochrome bo and bd
complexes [33–35]. Puriﬁed rTAO protein is highly active and exhibits
an exceptional stability upon storage. The analysis of the prosthetic
groups by inductively coupled plasma-mass spectrometer (ICP-MS)
and electron paramagnetic resonance (EPR) reveals the presence of
two ferric ions stoichiometrically bound per rTAO monomer. To our
knowledge this is the ﬁrst direct conﬁrmation of two ferric irons per
AOX. Furthermore we show that puriﬁed rTAO is potently inhibited by
ascofuranone with mixed function kinetics.
2. Materials and methods
2.1. Preparation of membrane sample
The strain FN102/pTbAO carrying cDNA for T. b. brucei TAO [36]
was pre-cultured at 37 °C in 100 ml of LB medium containing 10 mg
ampicillin, 5 mg kanamycin, and 5 mg 5-aminolevulinic acid for
4–6 h. The pre-cultured cells were aerobically grown at 30 °C in 10 l of
S-medium containing 100 g tryptone peptone, 50 g yeast extract, 50 g
casamino acid, 104 g K2HPO4, 30 g KH2PO4, 7.5 g trisodium-citrate·2H2-
O, 25 g (NH4)2SO4, 0.5 g MgSO4·7H2O, 0.25 g FeSO4·7H2O, 0.25 g FeCl3,
0.2%(w/v) glucose, and 1 g carbenicillin. The culture was initiated at O.
D.600=0.01 and expression of rTAO was induced by the addition of
isopropyl β-D-1-thiogalactoside (IPTG) (25 μM) at O.D.600=0.1. Cells
were harvested 8–10 h following induction and were resuspended in
50 mM Tris–HCl (pH 7.5) containing 20%(w/w) sucrose, 0.1 mM
phenylmethane sulfonyl ﬂuoride (PMSF) and protease inhibitor
cocktail (Sigma) and broken by a French Pressure Cell (Ohtake,
Tokyo). Unbroken cells were removed by centrifugation at 8000 g for
10 min (Hitachi 21G). Inner membranes of FN102/pTbAO were
fractionated in high density sucrose after ultracentrifugation at
200,000 g for 1 h at 4 °C (Hitachi 85H) (35 ml of supernatant was
overlaid over 35 ml of 50 mM Tris–HCl pH 7.5 containing 40%(w/w)
sucrose per ultracentrifuge tube). Buoyant inner rich membranes upon
40%(w/w) sucrose layer were fractionated and the inner membrane
pellet was separated by further ultracentrifugation at 200,000 g for 1 h
(HITACHI 85H). Themembrane pellet was resuspended in 50 mMTris–
HCl (pH 7.5) containing 20%(w/w) sucrose.2.2. Solubilization
Membranes were treated with solubilization buffer (6 mg/ml
protein in 50 mM Tris–HCl, 1.4%(w/v) n-octyl-β-D-glucopyranoside
(OG), 200 mM MgSO4, 20%(v/v) glycerol, pH 7.3) at 4 °C and imme-
diately ultracentrifuged at 200,000 g for 1 h at 4 °C. The quinol oxidase
activities of the samples before centrifugation, as well as that of
supernatant and pellet were determined.
2.3. Puriﬁcation of rTAO
Hybrid batch/column procedure described in the manufacturer's
instruction was used as stated below. Ten milliliter of the resin (BD
Bioscience, TALON Metal Afﬁnity Resin) was equilibrated in a batch
format by 100 ml of equilibration buffer (20 mM Tris–HCl, 1.4%(w/v)
OG, 100 mM MgSO4, 20%(v/v) glycerol, pH 7.3). Twenty milliliter of
OG extract was mixed with the resin for 20 min at 4 °C. The resin was
washed twice with 100 ml of wash buffer (20 mM Tris–HCl, 20 mM
imidazole, 0.042%(w/v) n-dodecyl-β-D-maltopyranoside (DM), 50 mM
MgSO4, 20%(v/v) glycerol pH 7.3) and the resin bound rTAO was
transferred to a column for additional washing with 20 ml of second
wash buffer (20 mM Tris–HCl, 165 mM imidazole, 0.042%(w/v) DM,
50 mM MgSO4, 20%(v/v) glycerol pH 7.3; ﬂow rate 1 ml/min) and
protein elution. Finally, rTAO was eluted with elution buffer (20 mM
Tris–HCl, 200 mM imidazole, 0.042%(w/v) DM, 50 mMMgSO4, 60 mM
NaCl, 20%(v/v) glycerol pH 7.3; ﬂow rate 1 ml/min). Fractions (4 ml
each) were collected.
2.4. Quantitative analysis of metals and EPR spectroscopy
Three independent preparations of rTAO were analyzed (details in
Section 3). Each sample solution containing 0.1 g of rTAO was added
to 1 ml of nitric acid and 7 ml of water. Organic compounds were
hydrolyzed by microwave-assisted protein digestion system (Ethos
Pro, Milestone General). Fe, Mn, Cu, Zn and Co in each sample were
quantiﬁed by inductively coupled plasma-mass spectrometer (ICP-
MS, ELAN DRC PerkinElmer Japan). Analysis was performed by the
Sumika Chemical Analysis Center (Osaka, Japan). Protein concentra-
tion was determined by the Lowry method.
EPR spectra were recorded on a JEOL X-band JES-FA300 spec-
trometer equipped with an ES-CT470 Heli-Tran cryostat system and a
Scientiﬁc Instruments digital temperature indicator/controller model
9700a. For EPR analysis of rTAO, 13 mg/ml puriﬁed rTAO was frozen
in EPR tubes in liquid nitrogen. The puriﬁed rTAO was reduced by
2 mM dithionite and 1 mM phenazine methosulfate prior to freezing.
2.5. Ubiquinol oxidase assay
Ubiquinol oxidase activity was measured by recording the absor-
bance change of ubiquinol-1 at 278 nm (Shimadzu spectrophotom-
eter UV-3000). Reactions were started by the addition of ubiquinol-1
(ﬁnal concentration 150 µM, ε278=15,000 M−1 cm−1) after 2 min
preincubation at 25 °C in the presence of rTAO and 50 mM Tris–HCl
(pH 7.4). For the enzyme kinetics of puriﬁed rTAO, the reaction was
initiated by the addition of ubiquinol-1 after 2 min preincubation at
25 °C in the presence of rTAO and 50 mMTris–HCl (pH 7.4) containing
0.05%(w/v) octaethylene glycol-monododecylether detergent
(C10E8).
2.6. Chemicals
All chemicals were biochemistry grade. Ubiquinone-1 and prote-
ase inhibitor cocktail were purchased from Sigma-Aldrich. The other
detergents were purchased from Dojin Chemicals (Tokyo, Japan).
Fig. 1. SDS-PAGE and Western blotting of rTAO in puriﬁcation steps. A: CBB-staining
12.5% SDS-PAGE of each fraction from the cobalt column chromatography. Lane 1,
marker; lanes 2 and 3, each 5 ml of OG extract and ﬂow through fraction; lane 4, 500 ml
of wash fraction; and lane 5, 60 ml of eluted fraction collected from fractions 6–12.
Loading samples on lanes 2 to 5 were precipitated with acetone. B: Western blot of
puriﬁed rTAO. The same sample to lane 5 in panel B was electrophoresed on 12.5%
polyacrylamide gel. Monoclonal antibodies were used against highly puriﬁed rTAO
obtained by a nickel column in the presence of guanidine. Epitope recognized by this
antibody is the C-terminal domain of the enzyme. The arrow indicates rTAO with an
apparent molecular mass of 34 kDa.
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3.1. Puriﬁcation of fully active TAO
Although we previously established a protocol for the overpro-
duction of rTAO in E. coli FN102 (ΔhemA) lacking cytochrome bo and
bd complexes of the bacteria, the yield of the active enzyme was too
low to analyze its prosthetic group [36]. Such a preparation also
hampered the determination of kinetic parameters of rTAO such as its
molecular activity. Therefore, conditions for the expression of rTAO
and puriﬁcation protocols were optimized to obtain large quantities of
active and stable rTAO to enable such determinations. Three factors
were critical to obtain large amounts of active rTAO, namely, growth
time of the culture prior to addition of IPTG, absolute concentration
of IPTG, and the use of puriﬁed inner membranes as the starting
material.
After extensive screening of detergents and additives to establish
the procedure for efﬁcient extraction of active rTAO from the inner
membranes, we found that n-octyl-β-D-glucopyranoside (OG) specif-
ically solubilized rTAO as shown in Table 1 (speciﬁc activity increased
from 23.3 to 63.2 µmol/min/mg after solubilization). Approximately
60% of the membrane quinol oxidase activity was recovered with
1.4%(w/v) OG in the extract (Sup. Fig. 1). Thus, recovery of the activity
was signiﬁcantly higher than that of previously reported digitonin
extraction (17%) [36]. Following solubilization, it was possible to
maintain enzymatic activity for at least 1 month at 20 °C.
Since rTAO was fused with N-terminal histidine tag, solubilized
rTAO was puriﬁed by cobalt afﬁnity chromatography. Although the
enzyme solubilized by OG was bound to the cobalt afﬁnity resin in
the presence of OG, it was not possible to elute bound rTAO from the
resin with buffer containing OG. Interestingly, however, we found
that 100% of the rTAO activity could be recovered from the column
when OG in the washing and elution buffers was exchanged with
n-dodecyl-β-D-maltopyranoside (DM). In the ﬁnal step, puriﬁed
rTAO was obtained by a two-step elution with 165 mM and 200 mM
imidazole, which resulted in a very efﬁcient puriﬁcation of active
rTAO in the presence of DM. A typical elution proﬁle of quinol oxidase
activity with increasing imidazole concentration is shown in Sup.
Fig. 1B. Puriﬁed rTAO, with a molecular mass of 34 kDa, was estimated
to be 95% pure by SDS-PAGE (Fig. 1A, lane 5). In addition to the 34 kDa
band, it is apparent that other bands are also present including two
with a smaller size than rTAO and one band with an approximate
molecular mass of 74 kDa. Since all of these bands were recognized
in Western blot using a monoclonal antibody against TAO (Fig. 1B),
the smaller protein bands possibly represent proteolytic breakdown
products whilst the 74 kDa band most likely represents the dimeric
form of rTAO. The speciﬁc activity of puriﬁed rTAO was more than
200 μmol/min/mg protein when 150 µM of ubiquinol-1 was used as a
substrate, which had a ﬁve-fold higher activity than that of the pre-
viously puriﬁed rTAO (approximately 40 µmol/min/mg) [36]. Quinol
oxidase activity of puriﬁed rTAOwas insensitive to 5 mMKCN but was
completely inhibited by 10 nM ascofuranone. A greater than 35-fold
increase in puriﬁcation was achieved using the techniques described
above, and 13.2% of the total activity was recovered from the lysate ofTable 1
Puriﬁcation of rTAO.
Fractions Total activity
(µmol/min)
Protein
(mg)
Speciﬁc activity
(µmol/min/mg)
Recovery
(%)
E. coli lysate 14100 2410 5.85 100
Inner membrane 3500 150 23.3 24.8
OG extract 2400 37.9 63.2 17.0
Co-column 1860 8.95 207 13.2
The activities listed here were measured using 150 µM of ubiquinol-1. Fractions (eluate
numbers 6–13 in Supplemental Fig. 1B) were collected as puriﬁed rTAO after co-
column.FN102/pTAO cells as summarized in Table 1. Such procedures resulted
in approximately 10 mg of highly puriﬁed rTAO from a 10 l culture.
3.2. Iron content in puriﬁed TAO
Since a highly active and stable puriﬁed rTAO could be obtained by
the protocol described above, the metal content of puriﬁed rTAO was
measured by ICP-MS. On the basis that TAO has a diiron center as
previously proposed [23,24], then two equivalents of iron should be
detected per monomer of rTAO. To this end we analyzed the iron
content of puriﬁed native rTAO, inactive rTAO, denatured rTAO, and
iron within the buffer eluted from the cobalt-column. Puriﬁed native
rTAOs derived from three independent E. coli cultures were precipi-
tated by PEG 3350 and resuspended in the elution buffer at three
different concentrations as shown in Sup. Table 1. To prepare inactive
rTAO, precipitated rTAO was resuspended in 50 mM Tris–HCl pH 7.4,
which resulted in complete loss of enzyme activity. Denatured rTAO
was prepared by resuspending the precipitant in elution buffer con-
taining 6 M guanidine–HCl and 0.3 M EDTA. Metal contents in these
preparations were 9000 ng/ml, 2900 ng/ml and 1800 ng/ml of Fe
respectively for the native rTAO (3.71, 1.19 and 0.80 mg/ml), 230 ng/
ml, 100 ng/ml and 28 ng/ml of Fe for inactive rTAO, denatured rTAO
and the elution buffer, respectively (Sup. Table 1). From these results,
the stoichiometry of bound iron per rTAOmonomer can be deduced as
indicated below, based on the following parameters namely, a molec-
ular mass of rTAO of 39,391 Da (including the 6×histidine tag), purity
of 95% based on SDS-PAGE gels, and the atomic weight of Fe being
55.85. Thus the ratio of iron atoms per rTAO is 1.76 for native rTAO
and 0.2 and 0.08 in inactive rTAO and denatured rTAO, respectively
(Table 2). This data indicates that one monomer of TAO possesses two
atoms of iron which are released during inactivation or denaturation
of the enzyme. To our knowledge, this is the ﬁrst direct measurement
of iron in puriﬁed AOX and the stoichiometry is consistent with the
active site of AOX being a diiron carboxylate-center.
Other metals including Mn, Cu and Zn were also analyzed (Sup.
Table 1). In all cases, these metals were below their detection limit
(10 ng/ml sample solution) or background level. Although cobalt was
Table 2
Ratio of metals to puriﬁed rTAO.
Fe/rTAO Zn/rTAO Mn/rTAO Cu/rTAO
Mean±S.D.
Native rTAO 1.76±0.077 0.03±0.013 N.D.a N.D.
Inactive rTAO 0.22b N.D. N.D. N.D.
Denatured rTAO 0.08b N.D. N.D. N.D.
Stoichiometric ratio of metals to one molecular TAO was calculated using data in
Supplemental Table 1.
a N.D. represents Not Detected (below 0.01).
b The value is an average of two independent experiments.
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cobalt in the elution buffer derived from the resin (data not shown).
Similarly although 130 ng/ml, 66 ng/ml and 61 ng/ml of Zn were
detected in native rTAO, these amounts of Zn were not commensurate
with that of the enzyme stoichiometry. The detected Zn might be
derived from the Zn-substituted form of rTAO, which was suggested
to be possible from structural analysis [37]. In addition, at least 90% of
the puriﬁed rTAO retained its prosthetic group in its active form.
In addition to measuring the stoichiometry of iron in puriﬁed
rTAO, EPR analysis of puriﬁed rTAO was also performed in order to
conﬁrm that puriﬁed rTAO was indeed a diiron carboxylate protein
and whether the detected iron originated from a diiron binding
center. As shown in Fig. 2, a low ﬁeld EPR signal at approximately
g=15 in the perpendicular EPR mode was observed with the reduced
form of rTAO when the enzyme was reduced by 2 mM of dithionite
and 1 mM of phenazine methosulfate (PMS), although the intensity of
the signal was low. Importantly the signal disappeared in the oxidized
form of rTAO. This low ﬁeld EPR signal is characteristic for diiron
proteins and is ascribed to an exchange-coupled high spin ferrous iron
[38]. Although this signal is not normally observed in the perpendic-
ular mode, it can be detected under certain conditions as outlined inFig. 2. EPR spectra of rTAO. A: Oxidized form of rTAO (360 µM). B: Reduced form of
rTAO (360 µM), which was treated by 2 mM of dithionite and 1 mM phenazine
methosulfate for 30 min on ice. Instrument parameters: microwave frequency,
9.02 GHz; microwave power, 1 mW; modulation frequency, 100 kHz; modulation
amplitude, 0.6 mT; and temperature of 5 K.this report [39]. The effective g-value of 15 observed in the perpen-
dicularmode is slightly lower than the value of 16 previously observed
by us [31] but this is probably due to the fact that parallel-mode EPR
spectroscopy is a much more sensitive probe than the perpendicular
mode. Nevertheless the ﬁnding of a low ﬁeld signal when the puriﬁed
enzyme is reduced is further conﬁrmation that the puriﬁed rTAO we
report here is indeed a diiron carboxylate protein. It should be noted
however that we were unable to observe the g=15 signal when the
enzyme was reduced by more physiological reductants such as
ubiquinol-1 the reasons for which are, at present, unclear.
3.3. Kinetic properties of puriﬁed TAO
Kinetic analysis of puriﬁed rTAO (or AOX) using ubiquinone analogs
has previously proved difﬁcult because: 1) the enzyme, following
solubilization, was extremely unstable, 2) the natural substrate of
trypanosomeAOX is ubiquinol-9 [4], which is too hydrophobic to use as
the substrate in the assay and 3) the enzymatic activity was not
saturated at themaximumconcentration of ubiquinol-1 (approximately
300 µM). Since we have puriﬁed rTAO in a fully active form and
conﬁrmed the stoichiometric presence of the diiron center, the puriﬁed
rTAO was well-suited to a kinetic analysis.
As noted in our earlier study [36] and inAOXs fromother organisms
[40] non Michaelis–Menten kinetics is observed when ubiquinol-1 is
used as a substrate. Hoefnagel et al. [40], however, observed that the
addition of a speciﬁc detergent (0.025% EDT-20) during the assay
increased the activity by 3- to 4-fold close to saturation. Although the
addition of 0.025%(w/v) of EDT-20 equally enhanced the activity of
puriﬁed rTAO by approximately 2-fold, it did have a deleterious effect
upon the long term stability of the enzyme (Sup. Fig. 2).
In an attempt to overcome this problem, various detergents were
therefore screened to determine if they could enhance activitywithout
affecting enzyme stability. When the effect of the detergents on
enzyme activity was evaluated by monitoring the activity of rTAO in
the presence of detergent (Sup. Fig. 3), most activity was retained in
the presence of 0.05%(w/v) of C10E8 (Sup. Fig. 4A). Light scattering at
400 nm conﬁrmed that at least 600 µM of ubiquinol-1 was soluble in
the assay system (Sup. Fig. 4B). The kinetics of ubiquinol-1 oxidation
by puriﬁed rTAO in the presence of 0.05%(w/v) of C10E8 showed
typical Michaelis–Menten kinetics (Fig. 3, Km of 338±23.2 µM and
Vmax of 601±27.0 µmol/min/mg). In contrast, activity was linearly
dependent upon substrate concentration in the absence of detergent
indicating unsaturation in agreement with previous studies [36,40]
(Fig. 4). Enzymatic analysis was performed with a wide range ofFig. 3. Kinetics of ubiquinol-1 oxidation by puriﬁed rTAO. S–V plot of ubiquinol oxidase
activity is shown using 75 ng of puriﬁed rTAO in 50 mM Tris–HCl (pH 7.4) and
ubiquinol-1 (80–580 µM) with (○) and without (△) 0.05%(w/v) C10E8 at 25 °C. The
solid line indicates the ﬁtted Michaelis–Menten kinetics with the detergent (Km of
338±23.2 µM and Vmax of 601±27.0 µmol/min/mg), whereas the dashed line indi-
cates the linear relationship between the substrate concentration and the activity
without the detergent.
Fig. 4. Kinetics of ubiquinol-2 oxidation by puriﬁed rTAO. S–V plot of ubiquinol oxidase
activity is shown using 75 ng of puriﬁed rTAO in 50 mM Tris–HCl (pH 7.4) and
ubiquinol-2 (10–150 µM)with (△) 0.05%(w/v) C10E8 andwith (○) 0.025%(w/v) EDT-
20 at 25 °C. The solid line indicates the ﬁtted Michaelis–Menten kinetics in the concen-
tration range below 90 µM of ubiquinol-2 with 0.025%(w/v) EDT-20, whereas the
dashed line does with 0.05%(w/v) C10E8 (Km of 71±1.2 µM and Vmax of 1,460±
53.2 µmol/min/mg with 0.025%(w/v) EDT-20, whereas Km of 57±8.5 µM and Vmax of
691±28.0 µmol/min/mg with 0.05%(w/v) C10E8).
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Km–1.7 Km.
To investigate whether the length of the side chain of the substrate
affected the kinetic properties of rTAO, a kinetic analysis using
ubiquinol-2 in the presence of EDT-20 and C10E8 (Fig. 4) was
performed. Fig. 4 indicates that during the oxidation of ubiquinol-2,
enzyme activity decreased above 100 µM substrate even in buffers
containing either detergent. Although kinetic parameters using
ubiquinol-2 could not be obtained due to substrate inhibition, S–V
plots in the concentration range below 90 µM of ubiquinol-2 could be
used to qualitatively analyze the effects of side chain on enzyme
activity. Calculated values from such plots revealed that in the pres-
ence of 0.025%(w/v) EDT-20 the Km (ubiquinol-2) was 71±1.2 µM
and Vmax=1460±53.2 µmol/min/mg whereas with, 0.05%(w/v)
C10E8 the Km was 57±8.5 µM and Vmax=691±28.0 µmol/min/mg.
Ascofuranone is a highly speciﬁc and potent inhibitor of TAO [7]
and it was therefore of importance to determine its inhibitory effect on
ubiquinol-1 oxidation by puriﬁed rTAO in the presence of 0.05%(w/v)
of C10E8 (Sup. Fig. 5A). From the data presented in Sup. Fig. 5A the
apparent kinetic parameters of ubiquinol-1 oxidation in the presence
of 0.5 nM and 2 nM of ascofuranonewere estimated to be respectively
Km
0.5 nM=368±6.4 µM; Vmax0. 5 nM=490±22.4 µmol/min/mg and
Km
2 nM=492±7.2 µM; and Vmax2 nM=309±60.5 µmol/min/mg. The
increased Km and decreased Vmax values (Sup. Fig. 5B) indicate that
ascofuranone inhibits puriﬁed rTAO in a mixed-type non-competitive
manner with respect to ubiquinol-1.4. Discussion
The overall goal of the present study was to obtain a highly pure
and stable rTAO protein with maximum speciﬁc activity which could
be used to investigate the kinetic properties of the enzyme. The
quality of the puriﬁed rTAO obtained in this study has resulted in
three important aspects with respect to the structure of AOX namely,
the ﬁrst direct evidence of stoichiometrically bound iron within the
diiron center of rTAO, secondly reliable measurements of kinetic
parameters and thirdly that a sample of sufﬁcient purity and yield
could be produced that has resulted in the formation of crystals [41].4.1. Overexpression and puriﬁcation of rTAO
The difﬁculties in isolating stable AOXs in an active form have
hampered the biochemical and structural analyses of the enzyme
including identiﬁcation of its prosthetic groups, tertiary structural
analysis and the deﬁnition of enzyme kinetic parameters. The present
study reports on the overexpression and puriﬁcation of active rTAO,
which has enabled us to study biochemical and protein chemistry
properties of this enzyme. The protocol described in this paper results
in the puriﬁcation of large amounts of stable rTAO with high speciﬁc
activity. Two factors appeared critical to functionally express highly
active rTAO. Firstly, the optimization of culture conditions, including
culture duration and IPTG concentration, was crucial for the suc-
cessful overexpression of rTAO with high speciﬁc activity. Secondly,
activity was maximized when rTAO was puriﬁed from E. coli inner
membranes—activity decreased substantially when it was isolated
from an unpuriﬁed membrane fraction. Additionally, changing the
detergent from OG to DM following solubilization, also appeared
important to maximize yield and activity. Puriﬁed rTAO produced in
this manner retained complete activity for more than 6 months at 4 °C
and for more than 1 month at 20 °C. Furthermore, we have also been
able to purify Sauromattum guttatum rAOX by this procedure showing
the universality of the puriﬁcation protocol (Elliott, C.E., Kido, Y., Kita,
K. and Moore, A.L. unpublished observations).
It is anticipated that highly puriﬁed and active AOXwill open a new
directionwith respect to the investigation of the structure and reaction
mechanisms of AOXs and contribute to further progress on the study of
this novel terminal oxidase. Indeed we recently took advantage of the
exceptional stability and purity of the rTAO by performing the ﬁrst
FTIR spectroscopic investigation of any diiron protein [32]. Stepwise
reduction of the fully oxidized resting state of rTAO revealed two
distinct IR redox difference spectra. The ﬁrst of these, “signal 1”,
contained clear features that could be assigned to protonation of at
least one carboxylate group, further perturbations of carboxylic and
histidine residues, bound ubiquinone and a negative band that might
arise from a radical in the fully oxidized protein. A second IR redox
difference spectrum, “signal 2”, appeared more slowly (within ap-
proximately 1 h) once signal 1 had been reduced and is quite distinct
from the components which comprise signal 1. The exact identity of
the components which result in signal 2 await further investigations.
Such a study has not previously been possible with AOX preparations
because of protein instability at room temperature.4.2. Prosthetic group analysis
Prosthetic group analysis summarized in Table 2 revealed that in
highly stable and puriﬁed rTAO there are two equivalents of iron per
rTAO monomer with no other metals, including Cu, Mn and Zn, being
detected. EPR spectroscopy conﬁrms that the irons are part of a diiron
center since an EPR signal at g=15 could be detected (Fig. 2) when
rTAO is reduced by dithionite in the presence of PMS. The fact that this
signal can be detected in all AOXs examined to date suggests that the
signal is a characteristic signature of AOXs [30,31] and in agreement
with mutational analyses [18,25–29] is further conﬁrmation that TAO,
similar to AOXs in other organisms, is a diiron carboxylate protein.
Furthermore the data summarized in Table 2 revealed that when the
protein was either inactivated or denatured iron was released indi-
cating it is essential for TAO activity. Moreover, this data has
established biochemically the validity of predicting the presence of
a diiron center from amino acid sequence data, not only in AOX but
also in other membrane-bound diiron carboxylate proteins including
5-demethoxyquinone hydroxylase (CLK-1/Coq7) (which also has the
diiron binding motif EXXH). It is of interest to note that both AOX and
CLK-1/Coq7 utilize ubiquinol as substrate and both are involved in
respiration [42–44].
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The inclusion of C10E8 in the assay was found to be critical for the
kinetic analysis of TAO and the evaluation of inhibitors. In Table 3, we
have calculated fundamental kinetic parameters of TAO and com-
pared them to those of E. coli cytochrome bo oxidase complex and S.
cerevisiae ubiquinol–cytochrome c reductase [45]. These kinetic
constants provide a molecular rationale on how the alternative
pathway can effectively compete with other terminal oxidases,
although caution must be exercised in the interpretation of this data
as it is derived from experiments performed under non-physiological
conditions and substrates. Nevertheless Table 3 indicates that TAO has
a calculated kcat of 415±19 s−1 (on the basis that the purity of rTAO
is 95%), which is slightly higher than that of the cytochrome bo
oxidase complex (313 s−1), yeast ubiquinol–cytochrome c reductase
(153 s−1) and previous values reported for the plant AOX (186 s−1),
but considerably less than that calculated for cytochrome c oxidase
(770 s−1) [45–48]. Taking into account that the value of the speciﬁcity
constant (kcat/Km) of enzymatic reactions is known to be less than
109 M−1 s−1 (from the perspective of diffusion limited access of
substrates [49]), it is apparent from Table 3 that both cytochrome bo
oxidase and TAO have quite high and comparable catalytic activities.
These values suggest that the activation energy of both quinol oxidase
reactions are similar and furthermore that the quinol oxidase activity
of TAO is thermodynamically “alternative” to that of the cytochrome
bo complex. In contrast however, TAO does not appear to compete
effectively with the bc1 complex in terms of speciﬁcity constant and, if
the plant AOX possesses a similar speciﬁcity constant to that of TAO,
it would suggest that plant alternative oxidase activity would be
severely curtailed unless the conventional respiratory chain is limited
either through inhibition (which appears to be the case under
‘stressed conditions’) or through down regulation as appears to be the
case in thermogenic tissues [12,50,51].
Interestingly ubiquinol-2 oxidation by rTAO showed substrate
inhibition at concentrations above 100 µM in a manner similar to that
observedwhen the heterodimeric terminal ubiquinol oxidase of E. coli,
cytochrome bd oxidized ubiquinol-2 as substrate [52]. A lower Km
value of ubiquinol-2 than that of ubiquinol-1might be related not only
to its hydrophobicity but also could be a function of the isoprenoid
chain. The peculiar kinetics of ubiquinol-2 might be attributed to the
following two points; 1) competition for the ubiquinol-2 oxidation
site between the substrate and the product, and 2) the presence of
inactive intermediates of the enzyme related to the precise catalytic
mechanism.
Kinetic analysis of the mechanism of inhibition by the speciﬁc TAO
inhibitor ascofuranone (Sup. Fig. 5) indicates that it is a mixed-type
inhibitor with respect to ubiquinol-1. The discrepancy between the
mixed inhibition observed in this report and competitive inhibition as
reported in our previous study [36]might be due to the different assay
conditions used in the experiments described in this paper. In theTable 3
Kinetic parameters of quinol oxidases (with respect to ubiquinol-1).
Km
(µM)
Vmax
(µmol/min/mg protein)
kcat
(s−1)
kcat/Km
(µM−1 s−1)
TAOa 338±23.2 601±27.0 415±19 1.2
Cyt bo oxidaseb 61 – 313 5.2
Ubiquinol-cyt c
reductasec
13 – 220 16.9
The kcat value of cytochrome c oxidase is kcat=770 (s−1) [46].
All the kcat values listed here were obtained by dividing the Vmax by the concentration
of the enzymes (mol/mg protein).
a This study.
b E. coli cytochrome bo oxidase as in Sakamoto et al. [47].
c Ubiquinol–cytochrome c reductase from bovine heart as in Fato et al. [45].previous study, the kinetic parameters were based on apparent values
because enzymatic activity was calculated without detergents and
hence only low ranges of ubiquinol-1 concentrations (0.01 Km–0.3
Km) could be used. In contrast, the kinetic parameters reported in the
current study were determined with much higher reliability since in
the presence of C10E8, a muchwider range of ubiquinol-1 (0.4 Km–1.7
Km) could be used.
4.4. Unique feature of AOX
AOX is found in various organisms and recent genome database
searches have also identiﬁed AOX in different phyla of the Animalia
kingdom (Mollusca, Nematoda and Chordata) [17]. It has been
suggested that since AOX is absent from mammalian tissues TAO
could be a chemotherapeutic target, since it functions in the blood-
stream form of T. brucei as the only terminal oxidase and hence is
essential for the survival of trypanosomes [5,6]. As an AOX protein has
also been identiﬁed in Cryptosporidium parvum [53,54], which causes
diarrheal disease cryptosporidiosis, and the recombinant C. parvum
AOX is also sensitive to ascofuranone and as a result suggests that not
only could AOX be a potential drug target in a number of parasites but
furthermore ascofuranone could be used to treat a number of infec-
tions since this compound shows potent, broad-spectrum antimicro-
bial activity [53].
In addition to this clinical application, there is considerable interest
in the unique characteristics of the enzyme since the functions and
properties of TAO are clearly distinct from those of other bacterial
quinol oxidases. TAO is a cytochrome-independent and cyanide-
insensitive quinol oxidase, whereas cytochrome bo and bd complexes
are cytochrome-dependent and cyanide-sensitive quinol oxidases
[34,35]. Furthermore, TAO has various other physiological roles in
T. brucei; the cytochrome and alternative pathways are both active
and functional in the procyclic forms [55] in addition to the blood-
stream form, thereby possibly providing metabolic ﬂexibility under
changing environmental conditions. TAO activity also appears to
regulate the expression of one of the major surface coat proteins,
GPEET, in the procyclic form [56], and in addition may regulate the
observed programmed cell death-like phenomena in the bloodstream
forms [57].
5. Conclusions
The primary aim of our research on TAO is to elucidate the inter-
action between the enzyme and its substrate or inhibitor, which
hopefully could act as a structural guide for ongoing drug develop-
ment. In addition to the knowledge obtained from this study, further
studies on the inhibitory kinetics and structure–activity relationship of
ascofuranone derivatives, along with mutational analyses of TAO
[27,29] and X-ray structure analysis will undoubtedly have con-
siderable implications with respect to our understanding of how
the enzyme interacts with its substrate and inhibitors. A three-
dimensional structure of TAO with and without ascofuranone should
also shed light on the inhibitorymechanism of this potent drug, which
according to this study occurs via amixed-type inhibition. Such further
insights about the interaction between ascofuranone and the enzyme
will hopefully lead to a more rational design of more potent and safe
anti-trypanosomal drugs.
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